Harnessing the potency of scorpion venom-derived proteins: applications in cancer therapy
- PMID: 39361208
- PMCID: PMC11450130
- DOI: 10.1186/s40643-024-00805-0
Harnessing the potency of scorpion venom-derived proteins: applications in cancer therapy
Abstract
Despite breakthroughs in the development of cancer diagnosis and therapy, most current therapeutic approaches lack precise specificity and sensitivity, resulting in damage to healthy cells. Selective delivery of anti-cancer agents is thus an important goal of cancer therapy. Scorpion venom (SV) and/or body parts have been used since early civilizations for medicinal purposes, and in cultures, SV is still applied to the treatment of several diseases including cancer. SV contains numerous active micro and macromolecules with diverse pharmacological effects. These include potent anti-microbial, anti-viral, anti-inflammatory, and anti-cancer properties. This review focuses on the recent advances of SV-derived peptides as promising anti-cancer agents and their diagnostic and therapeutic potential applications in cancers such as glioma, breast cancer, prostate cancer, and colon cancer. Well-characterized SV-derived peptides are thus needed to serve as potent and selective adjuvant therapy for cancer, to significantly enhance the patients' survival and wellbeing.
Keywords: Anticancer agents; Cancer therapy; Drug development; Drug discovery; Peptide therapeutics; SV-derived peptides.
© 2024. The Author(s).
Conflict of interest statement
The authors have no financial or non-financial interest to disclose.
Figures





Similar articles
-
Pleiotropic Anticancer Properties of Scorpion Venom Peptides: Rhopalurus princeps Venom as an Anticancer Agent.Drug Des Devel Ther. 2020 Feb 27;14:881-893. doi: 10.2147/DDDT.S231008. eCollection 2020. Drug Des Devel Ther. 2020. PMID: 32161447 Free PMC article. Review.
-
Colon Targeted Eudragit Coated Beads Loaded with Optimized Fluvastatin-Scorpion Venom Conjugate as a Potential Approach for Colon Cancer Therapy: In Vitro Anticancer Activity and In Vivo Colon Imaging.J Pharm Sci. 2022 Dec;111(12):3304-3317. doi: 10.1016/j.xphs.2022.08.020. Epub 2022 Aug 23. J Pharm Sci. 2022. PMID: 36007556
-
Boosting curcumin activity against human prostatic cancer PC3 cells by utilizing scorpion venom conjugated phytosomes as promising functionalized nanovesicles.Drug Deliv. 2022 Dec;29(1):807-820. doi: 10.1080/10717544.2022.2048133. Drug Deliv. 2022. PMID: 35266425 Free PMC article.
-
Scorpion venom peptides: Molecular diversity, structural characteristics, and therapeutic use from channelopathies to viral infections and cancers.Pharmacol Res. 2023 Nov;197:106978. doi: 10.1016/j.phrs.2023.106978. Epub 2023 Nov 1. Pharmacol Res. 2023. PMID: 37923027 Review.
-
Hitchhiking with Nature: Snake Venom Peptides to Fight Cancer and Superbugs.Toxins (Basel). 2020 Apr 15;12(4):255. doi: 10.3390/toxins12040255. Toxins (Basel). 2020. PMID: 32326531 Free PMC article. Review.
Cited by
-
Unconventional Treatments for Pancreatic Cancer: A Systematic Review.Cancers (Basel). 2025 Apr 25;17(9):1437. doi: 10.3390/cancers17091437. Cancers (Basel). 2025. PMID: 40361364 Free PMC article. Review.
-
Invertebrate venoms: A treasure trove of bioactive compounds with anticancer potential.Arch Toxicol. 2025 Jul;99(7):2685-2698. doi: 10.1007/s00204-025-04032-0. Epub 2025 May 2. Arch Toxicol. 2025. PMID: 40316781 Review.
References
-
- Al-Asmari AK, Riyasdeen A, Abbasmanthiri R, Arshaduddin M, Al-Harthi FA (2016b) Scorpion (Androctonus bicolor) venom exhibits cytotoxicity and induces cell cycle arrest and apoptosis in breast and colorectal cancer cell lines. Indian J Pharmacol 48(5):537–543. 10.4103/0253-7613.190742 - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources